Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.76B | $5.97B | $6.12B | $6.21B | $6.72B | $7.34B | $7.11B | $7.39B | $7.09B | $7.10B |
| Revenue growth | — | 3.7% | 2.5% | 1.5% | 8.2% | 9.2% | -3.2% | 4.0% | -4.0% | 0.2% |
| Gross profit | $2.60B | $2.67B | $2.67B | $2.73B | $3.06B | $3.20B | $2.54B | $2.91B | $3.05B | $3.21B |
| Gross margin | 45.1% | 44.7% | 43.7% | 43.9% | 45.6% | 43.6% | 35.8% | 39.4% | 43.0% | 45.2% |
| Net income | $648M | $701M | $823M | $820M | $939M | $710M | $462M | $149M | $280M | $810M |
| Net margin | 11.2% | 11.7% | 13.4% | 13.2% | 14.0% | 9.7% | 6.5% | 2.0% | 3.9% | 11.4% |
| EPS (diluted) | $4.92 | $5.33 | $6.26 | $6.32 | $7.36 | $5.58 | $3.73 | $1.20 | $2.25 | $6.52 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $778M | $865M | $976M | $992M | $1.55B | $1.28B | $786M | $1.16B | $695M | $981M |
| Capital expenditures | $172M | $231M | $194M | $206M | $254M | $331M | $251M | $228M | $212M | $220M |
| Free cash flow | $606M | $634M | $782M | $786M | $1.29B | $945M | $535M | $930M | $483M | $761M |
| Share buybacks | $254M | $183M | $271M | $661M | $248M | $905M | $25.0M | $0.00 | $0.00 | $332M |
| Dividends paid | $398M | $412M | $450M | $490M | $533M | $558M | $571M | $583M | $595M | $602M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $401M | $418M | $131M | $111M | $871M | $319M | $183M | $367M | $202M | $167M |
| Total assets | $4.51B | $4.57B | $5.06B | $5.12B | $6.21B | $6.33B | $6.16B | $5.95B | $5.75B | $5.56B |
| Total liabilities | $4.21B | $4.03B | $4.33B | $4.56B | $5.30B | $5.74B | $5.43B | $5.56B | $5.26B | $5.08B |
| Long-term debt | $1.79B | $1.39B | $2.28B | $2.29B | $2.78B | $2.48B | $2.47B | $2.48B | $2.48B | $2.48B |
| Shareholders' equity | $297M | $542M | $726M | $559M | $908M | $411M | $556M | $220M | $328M | $321M |
| Retained earnings | $2.16B | $2.44B | $2.80B | $3.15B | $3.57B | $1.04B | $1.05B | $583M | $250M | $432M |
| Shares (wtd avg diluted) | 132M | 132M | 132M | 130M | 128M | 127M | 124M | 124M | 125M | 124M |
Every figure is extracted from CLOROX CO /DE/’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.